Acne

New Laser Used By Prominent Farmington Plastic Surgeon To Erase Melasma

Melasma From time immemorial, pregnant women and seniors have suffered from melasma — hyper-pigmentation — but a solution to the problem is here. The spots seem to appear darker and more numerous daily. The skin, so valued, takes on a darker, unwanted complexion. "No longer will women have to wake up in the morning and [...]

Posted in | Tagged , | Leave a response

Pregnancies Exposed To Accutane Despite Risk Management Program

Despite a mandatory program designed to prevent pregnant women from being exposed to the anti-acne medication Accutane and similar medications containing isotretinoin (a known teratogen or birth defect-causing agent), 122 pregnancies were exposed during the first year of the program, known as iPledge, a report revealed. The March of Dimes Foundation said it is evaluating [...]

Posted in | Tagged | Leave a response

Cause of Rosacea Discovered by UCSD Researchers

Rosacea skin disease cause Doctors can describe the symptoms of rosacea, a common inflammatory skin disease that causes facial redness and affects nearly 14 million Americans. They can tell patients what triggers can worsen their condition: spicy foods, heat, alcohol, even embarrassment. But until now, they could not explain what caused rosacea. A team of [...]

Posted in | Tagged , , | Leave a response

FDA Recommends Making Accutane iPledge Program More Flexible

An FDA advisory committee on Wednesday voted 18-0 to recommend more flexibility for the agency-sponsored iPledge program, which aims to prevent pregnancies among women using the acne drug isotretinoin, the Wall Street Journalreports. The recommendation comes after updated figures released by thepanel on Wednesday show that 178 out of 102,606 women participating iniPledge became pregnant [...]

Posted in | Tagged , | Leave a response

Spot on treatment for acne

Acne Treatment Drug A previously unknown side effect of an unnamed drug currently on the marketplace could be useful for treating acne, reports Chemistry %26amp; Industry, the magazine of the SCI. A UK company is about to start a Phase 1 trial with the drug involving 18 healthy human volunteers and the results are expected [...]

Posted in | Tagged , | Leave a response

West Nile Virus Risk To Humans Increasing

West Nile Virus The number of human cases of West Nile Virus is rising in Saskatoon Health Region, with six human cases now reported in the Health Region and a total of 17 human cases reported across the province. The number of mosquito pools testing positive for WNV has also increased. As the August long [...]

Posted in | Tagged , | Leave a response

Aesthera’s Breakthrough Painless Isolaz Therapy For Acne

Aesthera Corporation’s Isolaz painless acne therapy has been featured in the September issue of Vogue, the most widely read issue of the year. Featured as a unique treatment that gets rid of acne fast, the Isolaz therapy is mentioned as the first laser approved by the FDA to treat severe acne. %26quot;I haven’t been this [...]

Posted in | Tagged , | Leave a response

Wal-Mart Adds 11 Generic Drugs To Discounted Prescription Drug Program

Discounted Prescription Drug Program Wal-Mart Storeson Thursday announced that it will begin selling eight additionalgeneric drugs for $4 per 30-day prescription and severalfamily-planning drugs for $9, USA Today reports (Appleby, USA Today,9/28). The added medications include treatments for glaucoma, attentiondeficit disorder, attention deficit hyperactivity disorder, fungalinfections and acne (Albright, St. Petersburg Times,9/28). In addition, Wal-Mart [...]

Posted in | Tagged , , | Leave a response

FDA Approves ERBITUX As A Single Agent In Patients With Advanced Colorectal Cancer

ImClone Systems, Bristol-Myers Squibb Company announced that FDA has approved an update to the ERBITUX (Cetuximab) product labeling to include overall survival data as a single agent in epidermal growth factor inhibitor (EGFR)-expressing metastatic colorectal cancer (mCRC) patients after failure of both irinotecan- and oxaliplatin-based regimens. The approval of the supplemental biologics license application (sBLA) [...]

Posted in | Tagged | Leave a response

Cutanea Announces Promising Results In Rosacea Trial With Omiganan

Cutanea Life Sciences announced positive results from its completed Phase II clinical trial of Omiganan. The trial compared Omiganan 2.5% and 1% topical gel to vehicle in subjects with papulopustular rosacea. Study results demonstrated that the formulation was safe and well-tolerated at all doses tested. Among the once-daily treatment arms, a dose-dependent response was observed [...]

Posted in | Tagged | Leave a response

Omiganan Phase II Rosacea Study Demonstrates Promising Results

MIGENIX has been notified by its partner for the dermatologic applications of omiganan, Cutanea Life Sciences, that a recently completed Phase II rosacea study has demonstrated: – superior lesion count reductions and Treatment Success (as defined by Investigator Global Assessment scores), with once-daily (QD) omiganan 2.5% gel compared to 1% omiganan QD and vehicle at [...]

Posted in | Tagged | Leave a response

Introducing New Generation Of Spa Bed

The world’s largest manufacturer of indoor tanning beds will partner with the global leader of light therapy technology to create the next generation of the first-to-market tanning bed that offers rejuvenating light therapy. Indianapolis-headquartered ETS Tan has entered into an agreement in principle with Carlsbad, Calif.-based Photo Therapeutics for a licensing arrangement for Photo Therapeutic’s [...]

Posted in | Tagged | Leave a response

Previous — Next